Weight-loss jabs could prevent and treat addiction to alcohol, cigarettes and drugs, according to a large study. Experts ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

Weight-loss drug users were less likely to suffer many common addictions including to alcohol, cannabis, cocaine, nicotine, ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, drinking and opioid use disorders and addiction.

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Researchers identify the anterior insula as the brain region responsible for biasing decisions toward alcohol over social rewards in addiction.

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be ...

Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent the formation of new substance ​use disorders and alleviate ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.